Grown Rogue International (GRUSF) Free Cash Flow Growth (3y) (2016 - 2023)
Grown Rogue International (GRUSF) Free Cash Flow Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 39.19% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 118.79% |
| Apr 30, 2023 | 63.12% |
| Jan 31, 2023 | 66.91% |
| Jan 31, 2022 | 32.07% |
| Oct 31, 2021 | 6,462.33% |
| Jul 31, 2021 | -0.74% |
| Apr 30, 2021 | 52.02% |
| Jan 31, 2021 | 50.42% |
| Aug 31, 2018 | 27.41% |
| May 31, 2018 | 66.06% |
| May 31, 2017 | -33.69% |
| Nov 30, 2016 | -56.07% |
| Aug 31, 2016 | 2.05% |